CABOT CORP (CBT) research

CABOT CORP
ShareXLinkedInReddit
Sector
Chemicals
Last price
$79.47
As of

CABOT CORP (CBT): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-15.

As of . Source: SEC EDGAR filings for CBT. Method and limitations.

SHARE THIS CARD

Share the CBT intelligence card

A branded snapshot of CBT: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion CBT intelligence card preview
Post to X
LIVE TERMINAL

See CBT live in the terminal

Track CBT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live CBT terminal, free

Active signals for CBT

FREE, NO ACCOUNT

Every signal on CBT, as it fires

You are seeing 5 of 25 signals recorded on CBT since 2026-05-29.

The five above landed across 2 days. The other 20 were recorded on 5 other days. 20 of the 25 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in CBT (2026Q2)

Manager / securityMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLCCUSIP 127055101 · 2026Q2$44.4M0.02%,
Bridgewater Associates, LPCUSIP 127055101 · 2026Q2$4.3M0.02%,
D. E. Shaw & Co., Inc.CUSIP 127055101 · 2026Q2$1.9M0.00%,
CITADEL ADVISORS LLCCUSIP 127055101 · 2026Q2$850K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, CBT

CBT against its peers

CBT's operating margin of 16.7% ranks in the 82nd percentile of 18 Chemicals sub-industry peers, fiscal periods ending between 2025-05-31 and 2026-01-31.

MetricCBTPeer medianPercentilen
Revenue FY3.7B USD2.7B USD7021
Gross margin25.3%26.3%5018
Operating margin16.7%4.8%8218
Net margin8.9%2.3%8022
Return on equity21.4%3.4%8921
P / E13.2x20.3x510

Peers (22): AVNT, MEOH, CE, BCPC, ASH, SMG, NGVT, IOSP, EMN, CC, MTX, NEU, OLN, SSL, HUN, SCL, REX, RPM, FMC, PCT, KRO, KOP. Left out: SVYSF (no annual filing), SYNSY (no annual filing), SQM (period gap). Fiscal periods ending between 2025-05-31 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (CBT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more CBT signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to CBTand get the insider, 13F, options, and confluence read in one view.

Open the live CBT terminal, free